Recombinant Deoxyribonucleic Acid (rDNA) Technology - Global Market Outlook (2020-2028)
According to Stratistics MRC, the Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market is accounted for $141.76 billion in 2020 and is expected to reach $301.68 billion by 2028 growing at a CAGR of 9.9% during the forecast period. Some of the key factors propelling the market growth include increasing demand for recombinant and genetically modified products for human health, food and agriculture, increasing government funding regarding the use of recombinant DNA technology to solve the various food, healthcare and environmental issues, technological advancements in genomics, and expansion of biopharmaceutical industry. However, ethical challenges associated with gene therapy and stringent regulations for approval of the product are restricting the market growth.
Recombinant DNA technology involves the insertion of DNA fragments having a desirable gene sequence in a vector molecule. The technology is exploited for producing various human proteins such as hormones, enzymes, cytokines, and monoclonal antibodies in microorganisms. Recombinant DNA technology joints together DNA molecules from two various species which is then inserted into the host organism to produce a new genetic combination having a wide application in medicine, agriculture, and industry. Basic tools required in recombinant DNA technology include the enzymes, the vectors and host organism. It is widely used in manufacturing of medicine, gene therapy, and clinical diagnosis.
By component, the expression system segment is expected to grow at the significant rate throughout the forecast period, due to the ongoing developments for efficient protein expression and for its further isolation on a large scale. Majorly used expression systems are mammalian, bacterial, insects, and yeast. The development of cell lines such as HEK293 and Chinese Hamster Ovarian (CHO) has contributed to the significant share of mammalian expression systems. In addition, ongoing research studies to explore the potential of plant as expression system are expected to drive the adoption of plan expression systems for GM product development in the coming years.
On the basis of geography, Asia Pacific region is expected to witness a rapid growth rate over the forecast period. Countries such as India and China are expected to support the growth of Asia Pacific owing to the increasing government funding for research and development. Moreover, conducting clinical trials in Asian countries such as India are relatively less costly in comparison with the western countries. This has resulted in the migration of several global biopharmaceutical developers towards this region. Furthermore, Japan is recognized as one of the world’s largest per capita importers of food and feed developed using modern biotechnology tools. Japan’s regulatory system for GE crops continues to improve.
Some of the key players in Recombinant Deoxyribonucleic Acid (rDNA) Technology Market include Pfizer Inc., Novartis AG, Eli Lilly and Company, GlaxoSmithKline plc., Novo Nordisk A/S, Monsanto Company, F. Hoffmann-La Roche Ltd, Amgen Inc., Sanofi SA, Merck KGaA, Biogen Inc., Profacgen, Horizon Discovery Group plc, Genscript Biotech, Biocon Limited, Boehringer Ingelheim, Thermo Fisher Scientific, Inc., and Chiron Corporation.
• Cloning Vector
• Expression System
• Food & Beverages
• Healthcare & Disease
End Users Covered:
• Academic & Government Research Institutes
• Biotechnology and Pharmaceutical Companies
• Diagnostic Laboratories
• Biochemical Industry
• North America
o Rest of Europe
• Asia Pacific
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025 and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Select License Type
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.